ZA943152B - Purified heparin fractions,method for obtaining them and pharmaceutical compositions containing them - Google Patents

Purified heparin fractions,method for obtaining them and pharmaceutical compositions containing them

Info

Publication number
ZA943152B
ZA943152B ZA943152A ZA943152A ZA943152B ZA 943152 B ZA943152 B ZA 943152B ZA 943152 A ZA943152 A ZA 943152A ZA 943152 A ZA943152 A ZA 943152A ZA 943152 B ZA943152 B ZA 943152B
Authority
ZA
South Africa
Prior art keywords
obtaining
pharmaceutical compositions
compositions containing
heparin fractions
purified heparin
Prior art date
Application number
ZA943152A
Other languages
English (en)
Inventor
Jean-Francois Branellec
Jose Espejo
Philippe Picart
Original Assignee
Choya S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9446915&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA943152(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Choya S A filed Critical Choya S A
Publication of ZA943152B publication Critical patent/ZA943152B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
ZA943152A 1993-05-07 1994-05-06 Purified heparin fractions,method for obtaining them and pharmaceutical compositions containing them ZA943152B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9305534A FR2704861B1 (fr) 1993-05-07 1993-05-07 Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant.

Publications (1)

Publication Number Publication Date
ZA943152B true ZA943152B (en) 1995-01-09

Family

ID=9446915

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA943152A ZA943152B (en) 1993-05-07 1994-05-06 Purified heparin fractions,method for obtaining them and pharmaceutical compositions containing them

Country Status (26)

Country Link
US (1) US5599801A (es)
EP (1) EP0623629B1 (es)
JP (1) JP3529835B2 (es)
KR (1) KR100328095B1 (es)
CN (1) CN1066155C (es)
AT (1) ATE141618T1 (es)
AU (1) AU672291B2 (es)
BR (1) BR9401920A (es)
CA (1) CA2122930C (es)
CZ (1) CZ287889B6 (es)
DE (1) DE69400385T2 (es)
DK (1) DK0623629T3 (es)
ES (1) ES2093494T3 (es)
FI (1) FI107388B (es)
FR (1) FR2704861B1 (es)
GR (1) GR3021648T3 (es)
HK (1) HK1007432A1 (es)
HU (1) HU221595B (es)
IL (1) IL109587A (es)
MY (1) MY110862A (es)
NO (1) NO306952B1 (es)
NZ (1) NZ260460A (es)
PL (1) PL178294B1 (es)
RU (1) RU2133253C1 (es)
TW (1) TW438812B (es)
ZA (1) ZA943152B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5980865A (en) * 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
US6217863B1 (en) 1995-10-30 2001-04-17 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase I
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
IT1290814B1 (it) * 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
EP1109919A2 (en) * 1998-08-27 2001-06-27 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase i and ii
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
WO2000065521A2 (en) * 1999-04-23 2000-11-02 Massachusetts Institute Of Technology System and method for polymer notation
JP2003525946A (ja) * 2000-03-08 2003-09-02 マサチューセッツ インスティテュート オブ テクノロジー ヘパリナーゼｉｉｉおよびその使用
US8227449B2 (en) * 2000-03-30 2012-07-24 Glycores 2000 S.R.L. Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
IT1318432B1 (it) * 2000-03-30 2003-08-25 Inalco Spa Glicosaminoglicani derivati dal polisaccaride k5 aventi elevataattivita' anticoagulante ed antitrombotica e processo per la loro
ES2324701T3 (es) 2000-09-12 2009-08-13 Massachusetts Institute Of Technology Metodos y productos relacionados con heparina de peso molecular bajo.
AU2440802A (en) * 2000-10-18 2002-04-29 Massachusetts Inst Technology Methods and products related to pulmonary delivery of polysaccharides
US20050027117A1 (en) * 2000-12-18 2005-02-03 Pasqua Oreste Anticoagulant and antithrombotic LMW-glycosaminoglycans derived from K5 polysaccharide and process for their preparation
JP2002293804A (ja) * 2001-03-28 2002-10-09 Itoham Foods Inc 低分子量ヘパリンの製造法
JP4828795B2 (ja) 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
ITMO20040199A1 (it) * 2004-07-29 2004-10-29 Biofer Spa Procedimento per la purificazione da gruppi e n no rsidui di eparine a basso peso molecolare ottentite tramite nitrosazione.
JP2006291028A (ja) * 2005-04-11 2006-10-26 Q P Corp 低分子ヘパリンまたはその塩、ならびにその製造方法
EP1792621B1 (en) 2005-11-30 2012-04-04 Istituto di Ricerche Chimiche e Biochimiche "G. Ronzoni" Orally administrable heparin derivatives
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
US8435795B2 (en) * 2010-01-19 2013-05-07 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
CA2811186C (en) * 2010-09-14 2018-12-04 Michio Muguruma High purity heparin and production method therefor
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
CN102633905B (zh) * 2011-04-11 2014-10-08 南通天龙畜产品有限公司 一种肝素钠中不被亚硝酸降解且在肝素钠保留时间附近出峰的物质的去除方法
CN104045744B (zh) * 2014-06-26 2016-01-06 常州千红生化制药股份有限公司 达肝素钠的制备方法
CN104098716B (zh) * 2014-07-16 2015-04-22 南京健友生化制药股份有限公司 一种达肝素钠精品的生产方法
US10688249B2 (en) * 2015-06-11 2020-06-23 Virchow Biotech Pvt. Ltd. Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same
CN105294885A (zh) * 2015-11-23 2016-02-03 山东大学 一种新来源亚硝酸降解低分子肝素的制备方法
JP2021513593A (ja) * 2018-02-14 2021-05-27 バイオロジカル イー リミテッド ダルテパリンナトリウムを調製する改善された方法
RU186728U1 (ru) * 2018-10-19 2019-01-30 Федеральное государственное бюджетное образовательное учреждение высшего образования "МИРЭА - Российский технологический университет" Лабораторное устройство для отмывки порошковых продуктов химических реакций от посторонних примесей
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
CA3144968A1 (en) 2019-07-09 2021-01-14 Optimvia Llc Methods for synthesizing anticoagulant polysaccharides
CN110845641A (zh) * 2019-11-07 2020-02-28 中国药科大学 一种肝素寡糖及其在制备抗血管生成药物中的应用
CN110787489A (zh) * 2019-11-20 2020-02-14 江苏千牧生物科技股份有限公司 一种肝素钠加工使用的分离装置及加工的工艺
CN115304688A (zh) * 2022-08-25 2022-11-08 湖北亿诺瑞生物制药有限公司 一种达肝素钠的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
US4438261A (en) * 1980-05-19 1984-03-20 Riker Laboratories, Inc. Anticoagulant substance
US4351938A (en) * 1980-05-19 1982-09-28 Riker Laboratories, Inc. Anticoagulant substance
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity
FR2503714B1 (fr) * 1981-04-10 1986-11-21 Choay Sa Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
US5094815A (en) * 1988-05-18 1992-03-10 Cornell Research Foundation, Inc. Photolytic interface for HPLC-chemiluminescence detection of non volatile N-nitroso compounds
US5032679A (en) * 1988-12-15 1991-07-16 Glycomed, Inc. Heparin fragments as inhibitors of smooth muscle cell proliferation
IT1243300B (it) * 1990-12-20 1994-05-26 Fidia Spa Derivati dell'eparina
US5385937A (en) * 1991-04-10 1995-01-31 Brigham & Women's Hospital Nitrosation of homocysteine as a method for treating homocysteinemia

Also Published As

Publication number Publication date
PL178294B1 (pl) 2000-04-28
FI107388B (fi) 2001-07-31
DE69400385T2 (de) 1996-12-19
JP3529835B2 (ja) 2004-05-24
EP0623629A1 (fr) 1994-11-09
CA2122930A1 (en) 1994-11-08
MY110862A (en) 1999-05-31
CZ287889B6 (cs) 2001-03-14
FR2704861A1 (fr) 1994-11-10
TW438812B (en) 2001-06-07
CN1096034A (zh) 1994-12-07
HU9401446D0 (en) 1994-08-29
CN1066155C (zh) 2001-05-23
ATE141618T1 (de) 1996-09-15
HK1007432A1 (en) 1999-04-09
NO306952B1 (no) 2000-01-17
DK0623629T3 (da) 1996-12-23
AU6191294A (en) 1994-11-10
HU221595B (hu) 2002-11-28
CZ113294A3 (en) 1994-12-15
DE69400385D1 (de) 1996-09-26
NZ260460A (en) 1996-02-27
HUT70553A (en) 1995-10-30
JPH07126302A (ja) 1995-05-16
EP0623629B1 (fr) 1996-08-21
NO941686L (no) 1994-11-08
FI942095A0 (fi) 1994-05-06
GR3021648T3 (en) 1997-02-28
FR2704861B1 (fr) 1995-07-28
BR9401920A (pt) 1994-11-29
AU672291B2 (en) 1996-09-26
NO941686D0 (no) 1994-05-06
RU94015595A (ru) 1996-09-27
US5599801A (en) 1997-02-04
CA2122930C (en) 2000-10-24
IL109587A0 (en) 1994-08-26
IL109587A (en) 1997-04-15
RU2133253C1 (ru) 1999-07-20
KR100328095B1 (ko) 2002-06-20
ES2093494T3 (es) 1996-12-16
FI942095A (fi) 1994-11-08

Similar Documents

Publication Publication Date Title
ZA943152B (en) Purified heparin fractions,method for obtaining them and pharmaceutical compositions containing them
AU5079690A (en) Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis inflammation and as immunosuppressants
AU6875694A (en) A wood preservative composition, process for treating wood with the same, and wood treated with the same
TW354793B (en) Polycarbonate resin with high flowability and process for producing the same
HU9301543D0 (en) Method for reducing degradation of polymers caused by ultraviolet irradiation as well as polymer composition less susceptible to degradation under influence of ultraviolet rays
HUT61554A (en) Process for producing 2,8-dioxabicyclo/3.2.1/octane derivatives and pharmaceutical compositions comprising same
AU7873594A (en) Method for refinishing wood
EP0659867A3 (de) Verfahren und Vorrichtung zur thermischen Depolymerisation von Kunststoffen.
HUT61466A (en) Process for producing pharmaceutical compositions suitable for treating symptoms of detoxication cures
GB2211845B (en) Process for dechlorinating 4,5-dichlorofluoro-dioxolanes to obtain fluorodioxoles
AU7777794A (en) Melatonin derivatives for use in treating sleep disorders
AU8154791A (en) Process for producing oil and gas by cracking waste rubber
AU3492289A (en) Fluorine-containing copolymer, process for its production and curable composition
GB9505996D0 (en) High stability, organic tanning process
EP0685492A3 (de) Verfahren zur Herstellung molekulareinheitlicher hyperpolymerer Hämoglobine.
ATA252892A (de) Benzofuranylimidazolderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
HU207801B (en) Process for producing pharmaceutical composition for treating psoriasis
AU3555393A (en) Process for the purification of 1,1-dichloro-1-fluoroethane
ATE141614T1 (de) Neue peptidderivate im prozess von zelladhäsion wirksam, verfahren zur deren herstellung und pharmazeutische zusammensetzungen die sie enthalten
ATA236490A (de) Neue selenophenderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
LV5780A4 (lv) Pretkonvulsiju triazoÚ4,5-c¾piridina atvasinajumi
MY129219A (en) Stabilization of lacquers
ITMI913034A1 (it) Metodo per il trattamento chimico di tutte le sostanze organiche con un prodotto atto ad eliminare in modo rapido gli odori da esse emanati e per l'impiego del composto risultante come fertilizzante
CS83190A2 (en) Method of multiples' error correcting codes decoding that are built up at least of two bch codes
CS83090A2 (en) Method of multiples' error correcting codes decoding that are built up at least of two bch codes